Sweden-based TikoMed today announced an in vitro study examining the ability of the company's lead drug candidate ILB® to inhibit infection of human cells by four serotypes of Dengue virus (DENV1-4), two strains of Zika virus... READ →
Zika News/ October 3rd, 2022
Eliminating fake zika news with pharmacist, nurse, and physician review.
Sep 7 • 12:56 pm CDT
Sep 1 • 5:33 am CDT
The Financial Times recently reported Gary Dubin, president of Takeda's global vaccine business, said one of the company's brightest prospects is for a vaccine targeting a mosquito-borne disease, the Zika virus. Since 2016, Takeda has been... READ →
Aug 18 • 8:28 am CDT
The Zika virus outbreak in 2015 and 2016 left many children worldwide with devastating brain damage. The New York Times reported on August 16, 2022, how families and researchers find potential cures in the shadow of... READ →
Aug 5 • 11:20 am CDT
The peer-review Journal of Infectious Diseases published a study on August 4, 2022, that the Zika virus (ZIKV) may remain active in men for months after infection. While sexual transmission of ZIKV was confirmed in a... READ →
Jun 21 • 4:15 pm CDT
Singapore-based Duke-NUS Medical School and Johnson & Johnson (J&J) jointly launched today a new J&J Satellite Center for Global Health Discovery that will drive new solutions to mitigate the threat posed by flaviviruses such as dengue... READ →
For more articles, try our search.